tirzepatide/b6 Vertiglow | Our tirzepitide injections include B6. Why? Reduced side effects: Tirzepatide can be compounded with B12 to reduce nausea or with added Tirzepatide + B6 (Pyridoxine) |

Yes, tirzepatide (Mounjaro, Zepbound) can cause nausea and vomiting, which are among the most common side effects of this dual GIP and GLP-1 receptor agonist

Zepbound is available in two forms: Single-use prefilled pen (KwikPen) Single-use vial used with a needle and syringe Zepbound pens and vials come in the following strengths: 2.5 mg/0.5 mL 5 mg/0.5 mL 7.5 mg/0.5 mL 10 mg/0.5 mL 12.5 mg/0.5 mL 15 mg/0.5 mL Typical Starting Dosage The recommended starting dose of Zepbound is 2.5 mg once a week

Sergey Terushkin, MD, FACS , a board-certified surgeon with experience in metabolic health, bariatric care, and physician-guided weight management

Tirzepatide is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2